SCHEMBL2830563

SCHEMBL2830563

C=C1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 2/20 0.78
▸ SERPINA6 P08185 2/20 0.62
▸ ALDH1A1 P00352 2/20 0.62
▸ SHBG P04278 2/20 0.62
▸ SLC22A1 O15245 1/20 0.62
▸ THRB P10828 1/20 0.62
▸ PGR P06401 4/20 0.56
▸ CYP3A4 P08684 3/20 0.56
▸ LMNA P02545 2/20 0.56
▸ ABCB11 O95342 2/20 0.56
▸ TSHR P16473 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ HIF1A Q16665 1/20 0.56
▸ ESR1 P03372 1/20 0.56
▸ NR3C1 P04150 1/20 0.56
▸ ADRA2A P08913 1/20 0.56
▸ SLC6A4 P31645 1/20 0.56
▸ AR P10275 3/20 0.55
▸ NR3C2 P08235 2/20 0.55
▸ MEN1 O00255 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14871417 0.88 CYP19A1 (1.00) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL16387354 0.88 CYP19A1 (1.00) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL20088312 0.88 CYP19A1 (1.00) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL12413521 0.88 CYP19A1 (1.00) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL868884 0.88 CYP19A1 (1.00) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL17831183 0.88 CYP19A1 (1.00) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL11632217 0.88 CYP19A1 (1.00) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL17591556 0.88 CYP19A1 (1.00) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL21807725 0.88 CYP19A1 (1.00) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1
SCHEMBL11627782 0.88 CYP19A1 (1.00) CYP19A1SERPINA6ALDH1A1SHBGSLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0715517-B1 ESTRENE STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN HYPOTHALAMIC FUNCTION AND RELATED PHARMACEUTICAL COMPOSITIONS PHERIN PHARM INC (US) 2003-11-05 — — EP claimed
US-20100111896-A1 Items Containing A Human Pheromone Component MARENBERG BARRY J 2010-05-06 — — US disclosed
WO-2007062023-A2 ITEMS CONTAINING A HUMAN PHEROMONE COMPONENT BRAGINSKY PHILIP Y (US) 2007-05-31 — — WO disclosed
EP-0891188-A4 STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH PHERIN PHARM INC (US) 2004-09-01 — — EP disclosed
EP-0914165-A4 STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF PMS AND ANXIETY PHERIN PHARM INC (US) 2004-01-21 — — EP disclosed
US-6352980-B1 ADMINISTERING BY SPRAYING IN NOSE PHERIN PHARMACEUTICALS, INC. 2002-03-05 — — US disclosed
US-6331534-B1 ADMINISTERING EFFECTIVE AMOUNT OF STEROID WITHIN NASAL PASSAGE OF INDIVIDUAL SUCH THAT IT BINDS SPECIFICALLY TO RECEPTORS ON SURFACE OF NASAL NEUROEPITHELIAL CELLS IN VOMERONASAL ORGAN PHERIN PHARMACEUTICALS, INC. 2001-12-18 — — US disclosed
US-6117860-A NASALLY ADMINISTERING STEROID WHICH BINDS TO A SPECIFIC NEUROEPITHELIAL RECEPTOR FOR ALLEVIATING PREMENSTRUAL TENSION AND ANXIETY PHERIN PHARMACEUTICALS, INC. (US) 2000-09-12 — — US disclosed
US-6066627-A ALTERING BLOOD CONCNETRATION OF LUTEINIZING HORMONE PHERIN CORPORATION (US) 2000-05-23 — — US disclosed
US-6057439-A EPOXYSTEROIDS PHERIN CORPORATION (US) 2000-05-02 — — US disclosed
EP-0891188-A1 STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH Pherin Pharmaceuticals, Inc. (US) 1999-01-20 — — EP disclosed
WO-1998014194-A9 STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF ANXIETY — 1998-08-27 — — WO disclosed
WO-1998003207-A9 STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF PMS AND ANXIETY — 1998-05-22 — — WO disclosed
WO-1998014194-A1 STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF ANXIETY PHERIN PHARMACEUTICALS (US) 1998-04-09 — — WO disclosed
WO-1998003207-A1 STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF PMS AND ANXIETY PHERIN PHARMACEUTICALS, INC. (US) 1998-01-29 — — WO disclosed
WO-1997036596-A9 STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH — 1997-12-04 — — WO disclosed
WO-1997036596-A1 STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH PHERIN PHARMACEUTICALS, INC. (US) 1997-10-09 — — WO disclosed
EP-0783513-A1 NOVEL ESTRENES FOR INDUCING HYPOTHALAMIC EFFECTS PHERIN CORPORATION (US) 1997-07-16 — — EP disclosed
US-5633392-A STIMULANTS FOR AUTONOMIC NERVOUS SYSTEM; NOSE SPRAYING PHERIN CORPORATION (US) 1997-05-27 — — US disclosed
WO-1996010032-A1 NOVEL ESTRENES FOR INDUCING HYPOTHALAMIC EFFECTS PHERIN CORPORATION (US) 1996-04-04 — — WO disclosed
Send feedback